AzTrials
AzTrials

Primary Open Angle GlaucomaNCT06526416

The Objective is to Evaluate the Anterior Chamber Angle After BANG Procedure, the Study Will Recruit 12 Patients Who Will Undergo Planned Goniectomy for Uncontrolled POAG, Anterior Segment OCT Scan Will Be Used to Evaluate the Anterior Chamber Postoperatively.

An observational study of Primary Open Angle Glaucoma and Glaucoma, run by Benha University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Evaluation of anterior segment using anterior segment optical coherence tomography in patients undergoing planned bent angle needle goniectomy procedure for uncontrolled open angle glaucoma. Read more about this study

Who is it for?
Any age
Conditions the study is for
Primary Open Angle Glaucoma, Glaucoma
What is being tested?
Anterior segment optical coherence tomography
How many people
12 participants
Where
No sites listed yet
Study dates
1 Nov 2024to 1 Jan 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: patients presenting to Benha University Hospitals with open angle glaucoma.

Who may be able to join

  • Patients who are being treated for primary open angle glaucoma using eye drops.
  • Patients with uncontrolled intraocular pressure \>21 mm Hg
  • All recruited patients should have open anterior chamber angles demonstrated on gonioscopy examination.
  • Patients giving consent for operation and follow up

Who cannot join

  • 1- Pseudophakic patients 2- Advanced glaucoma patients. 3- Patients who are to have trabeculectomy or laser trabeculoplasty. 4- Patients with secondary glaucoma. 5- Patients who are unable to give consent for surgery or follow up. 6- Patients with previous trauma to the eye

Trial locations and contacts

No sites are listed yet.

Mohammed A Awwad, MSc, MD, PhD contact

+201017014208

mohamed.awad@fmed.bu.edu.eg

Nader H.F Hassan, MSc, MD, PhD contact

+201224727982

naderhf@fmed.bu.edu.eg

About this study

Official title: Anterior Chamber Angle Changes After Bent Angle Needle Goniectomy Procedure, Anterior Segment OCT Study

Evaluation of anterior segment using anterior segment optical coherence tomography in patients undergoing planned bent angle needle goniectomy procedure for uncontrolled open angle glaucoma.

Being tested
Anterior segment optical coherence tomography
Keywords
Bent angle needle goniectomy, anterior segment optical coherence tomography, Primary open angle glaucoma
Medical subject headings
Glaucoma, Open-Angle, Glaucoma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Anterior segment optical coherence tomographyOther

    Imaging of the anterior segment of the eye using optical coherence tomography

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To detect the changes in anterior chamber angle using Anterior segment OCT after BANG goniectomy

    To detect the changes in anterior chamber angle using Anterior segment OCT after BANG goniectomy

    Measured: 12 weeks after the day of surgery.

Secondary outcomes (1)
  1. To detect any correlation between the post-op anterior chamber angle changes and the intraocular pressure.

    To detect any correlation between the post-op anterior chamber angle changes and the intraocular pressure.

    Measured: 12 weeks after the day of surgery.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jul 2024
  2. Study start1 Nov 2024 (estimated)
  3. Primary completion1 Jan 2025 (estimated)
  4. Study completion1 Jan 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
12 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06526416
Sponsor's protocol ID
RC.50.5.2023
Status last verified
Jul 2024
First submitted
22 Jul 2024
Last updated
29 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Primary Open Angle Glaucoma and Glaucoma, run by Benha University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mohammed A Awwad, MSc, MD, PhD (+201017014208, mohamed.awad@fmed.bu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To detect the changes in anterior chamber angle using Anterior segment OCT after BANG goniectomy (time frame: 12 weeks after the day of surgery.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in